J.P.Morgan

J.P.Morgan is out with a report, where it has downgraded GeoEye, Inc. (GEOY) to “neutral” from “overweight”, and has set a price target at $37.00. YTD, GEOY has increased 25.9%. The analysts at J.P.Morgan noted, “Growth in 2011-2012 could be slow relative to 2009-2010, when GEOY experienced a...

In a recent report, analysts at J.P.Morgan reiterated its “overweight” rating on shares of Volcano Corporation (VOLC); a target price has been set at $29.00. The analysts at J.P.Morgan cited the company’s most recent earnings report, which exceeded consensus revenues and EPS expectations. A strong...

J.P.Morgan is out with a note, where it reported an “overweight” rating on DuPont (DD); and has increased its target price to $50.00 from $44.00. DuPont generated increased sales and lower expenses, which drove the company’s higher-than-anticipated EPS outperformance. J.P.Morgan stated, “We...

J.P.Morgan published a note this morning, where analysts reiterated its “neutral” rating on shares of Affymetrix (AFFX); and lowered its price target to $6.00 from $8.00. For 2Q, AFFX produced weak instrument sales due to delays in capital equipment purchasing in Europe, while consumables were also...

J.P.Morgan is out with a research report this morning, where it maintains its “neutral” rating on Knight Capital Group (KCG); with a price target of $18.00. Knight posted great 2Q10 results, with an EPS of $0.58 beating estimates of $0.39. Analysts noted that even though KCG posted a strong 2Q,...

Alliance Data (NYSE: ADS) reported core EPS of $1.38 in its 2Q, higher than the expected estimates of $1.31/$1.32 by J.P. Morgan/Street, but a new statement fee enforced by ADS has caused JPM to reduce price target $1 from $78 to $77, as ADS is expected a ~$0.30 drag on its EPS for 2H10. JPM...

J.P.Morgan published a report on their latest outlook for the plasma proteins market. Concerns about the health of the market continue to be an overhang for shares of Baxter (BAX) and other manufacturers. A German plasma manufacturer, Biotest, announced its 1H10 results Wednesday morning and...

After the market closed yesterday, Intel (INTC) reported 2Q10 EPS of $0.51, which was $0.07 above analysts at J.P.Morgan estimates. Revenue increased 5% QoQ which also beat estimates due to higher than expected server processor sales. J.P.Morgan analysts expect 3Q10 revenues to increase ~8% to $11...

J.P. Morgan is out with a research report this morning, where it reiterates its Overweight rating on shares of Vitamin Shoppe Inc. (NYSE: VSI); it has a $28.00 price target on the stock. The JPM analysts said, “Vitamin Shoppe will report 2Q10 EPS on July 22 (BMO), and we are modeling 7.0% SSS...

Analysts at JPMorgan have decided to downgrade paper markets to neutral. This downgrade comes from a decreased demand for paper due to the increase in unemployment. The demand for CWF and UCWF paper is highly correlated to the general health of the broader economy. CWF paper is used in printing...

After meeting with Brinker International (NYSE: EAT) executives, J.P.Morgan (NYSE: JPM) has lowered its price target to $20.00 from $24.00. Despite remaining optimistic about mid-term cost structure changes, Brinker's "near term mood [is] poor." J.P.Morgan lowered its F10 EPS to $1.18 versus $1.20...

J.P. Morgan analyst Paul Coster updated estimates for NCR (NYSE: NCR) today to reflect news contained in its latest 8-K SEC filing, submitted May 17, 2010. According to Coster, the 8-K form advised that the Blockbuster Express business should be EBIT breakeven by 4Q11 and will generate $25-$35mm...

Analysts at JP Morgan (NYSE: JPM) have released an update on Penn National Gaming, Inc. (NASDAQ: PENN). The company reported EBITDA of $120.9 million for the fourth quarter, in line with analysts’ estimate of $120.6 million. The company reported revenue of $556 million for the quarter, which was...

Analysts at JP Morgan (NYSE: JPM) have released a report reviewing the fourth-quarter at WABCO Holdings, Inc. (NYSE: WBC). The company reported strong results for the fourth quarter. The operating EPS of $0.36 came in ahead of analysts’ estimate of $0.34. The consensus forecast for EPS was of $0.29...

J.P.Morgan maintains a “Neutral” rating on Research In Motion Limited (USA) (NASDAQ: RIMM) after RIMM reported healthy third quarter financial results driven by a higher device shipment number. RIMM expects fourth quarter revenue to be in between $4.2 - $4.4 billion, versus the analyst’s current...